In July, the World Health Organisation (WHO) had also praised Dharavi for bringing COVID-19 under control

The Russian Direct Investment Fund (RDIF) is in talks with Indian company for large scale human trials of SputnikV vaccine

Approximately 60,000 were being conducted daily in Delhi for Covid-19 detection, according to Chief Minister Arvind Kejriwal

All Hyderabad vaccine companies are robust in manufacturing technology and have the capacity to manufacture millions of doses

Phase 1 and 2 trials on Russia’s Sputnik V vaccine have been completed

The ICMR guidelines suggest that 100 percent of people living in the containment zones should be tested by Rapid Antigen Testing

Agra is one of the 20 success stories which followed a model for door step delivery of essentials in 100 wards of the city

The teams of scientists have been selected through a rigorous binational review process of proposals received

ASEAN members have agreed to enable a supply chain connectivity for the provision of essential medical supplies including medicines

The new regulations allow refreshments and in-flight entertainment with due precautions

The results of the sero-survey to know the prevalence of antibodies against coronavirus among the populace are likely by September-end

She has worked on a microprocessor-based device that would keep people six feet apart

Till now, the government's emphasis has been primarily on RT-PCR (real-time polymerase chain reaction) testing and antigen testing

The Ministry of Corporate Affairs (MCA) has made two amendments in the Corporate Social Responsibility rules for companies

The Indian Council of Medical Research (ICMR) conducted the study at the All India Institute of Medical Sciences, Delhi

The Indian Council of Medical Research (ICMR) says tests are being conducted at nearly 1,500 laboratories

India has the potential to become an export hub with the added manufacturing capacities

Three Indian vaccines are in various trial stages and two under development

Scientists believe that the virus could be propagating from people infected asymptomatically

Several Indian firms are in the process of developing a Covid-19 vaccine amid the pandemic

Serum Institute of India (SII) has completed phase II-B3 trials and will start phase-III trial after clearances

Past track record of its drug manufacturing firms puts India above China in the supply of Covid-19 vaccine to the world

During Indian Foreign Secretary Harsh Shrigla’s visit to Dhaka, both sides discussed the possibilities of collaboration in Covid-19 vaccine development

Race for COVID-19 vaccine has gained speed, with the Serum Institute of India all set to produce 100 million doses of affordable COVID-19 vaccine for vulnerable countries